P-52 - OPTIMIZACIÓN DE TERAPIAS BIOLÓGICAS ANTI-TNFα, ANTI-INTEGRINA α4β7 Y ANTI-IL23P19 EN UN MODELO EXPERIMENTAL DE COLITIS INDUCIDA POR DSS

IF 2.2 4区医学 Q3 GASTROENTEROLOGY & HEPATOLOGY

Gastroenterologia y hepatologia Pub Date : 2025-01-01 DOI:10.1016/S0210-5705(25)00213-4

Fabio Suárez-Trujillo, Macarena Orejudo, Irene Soleto, Cristina Ramírez, Montse Baldán-Martín, Paula J. Martínez, Carlos H. Gordillo-Vélez, Danay Cibrián, Javier P. Gisberty María Chaparro

引用次数: 0

查看原文本刊更多论文

P-52 -在DSS引起的结肠炎实验模型中优化抗TNFα、抗肠素α4β7和抗IL23 - P19的生物疗法

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gastroenterologia y hepatologia GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

1.50

自引率

10.50%

发文量

147

审稿时长

48 days

期刊介绍： Gastroenterology and Hepatology is the first journal to cover the latest advances in pathology of the gastrointestinal tract, liver, pancreas, and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners.